Trexquant Investment LP Aclaris Therapeutics, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.56 - $10.95 $838,702 - $1.4 Million	127,851 New	127,851 $875,000
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $142,077 - $261,399	-14,587 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $178,982 - $269,713	14,587 New	14,587 $212,000
Q3 2021 Nov 12, 2021	SELL	$13.38 - $18.8 $181,365 - $254,834	-13,555 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$17.08 - $29.6 $231,519 - $401,228	13,555 New	13,555 $238,000
Q2 2018 Aug 07, 2018	SELL	$16.46 - $20.33 $332,854 - $411,113	-20,222 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$17.08 - $25.64 $345,391 - $518,492	20,222 New	20,222 $354,000
Q4 2017 Feb 09, 2018	SELL	$21.47 - $27.8 $205,661 - $266,296	-9,579 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$23.02 - $28.8 $220,508 - $275,875	9,579	9,579 $247,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.